Featured Posts

Tuesday, February 5, 2019

CytoSorbents to Present at the 21st Annual BIO CEO & Investor Conference

MONMOUTH JUNCTION, N.J., Feb. 5, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world,...

from PR Newswire: https://prn.to/2UKD1dd

No comments:

Post a Comment